Cidara Therapeutics to Present Ongoing Development of
SAN DIEGO, June 20, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics...
Source: globenewswire.com
📰 Preclinical Development News
Page 5 - Preclinical Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Preclinical Development. Real-time updates on events, politics, business and more.
Cidara Therapeutics to Present Ongoing Development of Drug-Fc Conjugates (DFC) Including CD73-Targeting DFC From Its Cloudbreak® Platform at Adenosine-Pathway Targeted Cancer Immunotherapy Summit
SAN DIEGO, June 20, 2023 -- Cidara Therapeutics, Inc. , a biotechnology company developing long-acting therapeutics designed to help improve the standard of care for patients facing serious... | June 20, 2023
Source: marketscreener.com
Xtalks Announces its Life Science Webinar Calendar for June 2023
Toronto, ON (PRWEB) June 02, 2023 -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical
Population Health Practices In Clinical Gene Therapy Method Development Precision Research Ecosystem For Real Honeycomb Worldwide Inc Tb Vaccine Development Optimal Cell Line Development
Source: prweb.com
Kinase Inhibitors for Inflammatory Diseases: Preclinical Development, Upcoming Webinar Hosted by Xtalks
Toronto, ON (PRWEB) May 25, 2023 -- Protein kinases act as master regulators of multiple key processes within the cell cycle, and aberrant regulation of their
United Kingdom Pauline Bornert Vera Kovacevic Study Research Oncodesign Services Preclinical Development
Source: prweb.com
Affini-T Therapeutics to Present AFNT-211 T Cell Product Attributes Targeting KRAS G12V at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
BOSTON & SEATTLE--(BUSINESS WIRE)--May 25, 2023--
Source: wsiltv.com
Sensorion Will Present Two Posters At The American Society Of Cell And Gene Therapy (ASGCT) 26th Annual Meeting
Regulatory News: Sensorion (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the ear, is pleased to announce its participation in the
United States Los Angeles David Lawrence Institut Pasteur Matthew Cole Jessica Hodgson Head Of Preclinical Development
Source: finanznachrichten.de
ARTHEx Biotech to Present Preclinical Data on ATX-01 for Myotonic Dystrophy Type 1 (DM1) at TIDES USA 2023 Meeting
/PRNewswire/ -- ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs,...
Source: prnewswire.com
Drug Discovery Outsourcing Market is anticipated to hold a share of US$ 7.52 billion by 2033
The Drug Discovery Outsourcing Market demand is anticipated to expand its roots at a steady CAGR of 7.2% between 2023 and 2033. The market is anticipated to cross a market share of US$ 7.52 billion by 2033, which is likely to be valued at US$ 3.75 billion in 2023.Expanding the pharmaceutical industry and the higher...
New York United States United Kingdom Service Type Outlook Lifesciences Pvt Ltd Syngene International
Source: pharmiweb.com
Clearside Biomedical Presents Compelling Data at The Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting
ALPHARETTA, Ga., April 27, 2023 -- Clearside Biomedical, Inc. , a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space ,... | April 27, 2023
United States South Korea New Zealand Triamcinolone Acetonide Suprachoroidal Remy Bernarda Dennism Marcus
Source: marketscreener.com
EQS-News: Immunic to Participate in Investor and Scientific Conferences in May
Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Investor and Scientific Conferences in May 26.04.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Investor and Scientific Conferences in May NEW YORK, A...
Source: boersennews.de